Page last updated: 2024-09-04

xylose and Graft-Versus-Host Disease

xylose has been researched along with Graft-Versus-Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ahmed, SS; Ajami, NJ; Alousi, AM; Brown, AN; Champlin, RE; Chang, CC; Chapa, VA; Chemaly, RF; Davey, L; El-Himri, RK; Flores, II; Frenk, AC; Galloway-Peña, J; Glowacki, RWP; Halsey, T; Hayase, E; Hayase, T; Heckel, BE; Jamal, MA; Jenq, RR; Jin, Y; Karmouch, JL; Liu, C; Lorenzi, PL; Martens, EC; McDaniel, LK; Miyama, T; Molldrem, JJ; Ortega, MR; Pham, D; Prasad, R; Rondon, G; Sanchez, CA; Shelburne, S; Shpall, EJ; Tan, L; Tsai, WB; Valdivia, RH; Veillon, L; Wargo, JA1
Peled, JU1

Other Studies

2 other study(ies) available for xylose and Graft-Versus-Host Disease

ArticleYear
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease.
    Cell, 2022, 09-29, Volume: 185, Issue:20

    Topics: Animals; Anti-Bacterial Agents; Bacteroides; Carbapenems; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Meropenem; Mice; Mucins; Mucus; Polysaccharides; Xylose

2022
Xylose versus Bacteroides in graft-versus-host.
    Cell host & microbe, 2022, 11-09, Volume: 30, Issue:11

    Topics: Bacteroides; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Transplantation, Homologous; Xylose

2022